株探米国株
日本語 英語
エドガーで原本を確認する
false 0001420520 0001420520 2025-05-06 2025-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): May 6, 2025

 

 

 

ATOMERA INCORPORATED

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware 001-37850 30-0509586
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number)

  

750 University Avenue, Suite 280

Los Gatos, California 95032

(Address of principal executive offices)

 

(408) 442-5248

(Registrant’s telephone number, including area code)

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock: Par value $0.001   ATOM   Nasdaq Capital Markets

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

     

 

Item 2.02 Results of Operations and Financial Condition.

 

On May 6, 2025, Atomera Incorporated issued a press release announcing its financial results for the three months ended March 31, 2025. The Company also intends to conduct an earnings call over which it will distribute an investor presentation. The text of the press release is attached hereto as Exhibit 99.1 and the investor presentation is attached hereto as Exhibit 99.2, both are incorporated by reference herein.

 

The information in this Current Report, including the exhibits attached hereto, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act regardless of any general incorporation language in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits  

 

The following exhibits are filed with this report:

 

Exhibit Number   Exhibit Description
99.1   Press release dated May 6, 2025 Atomera Incorporated
99.2   Investor presentation dated May 6, 2025 Atomera Incorporated
104   Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101).

 

 

 

 

 

 

 

 

  2  

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  ATOMERA INCORPORATED  
     
     
Dated: May 6, 2025 /s/ Francis B. Laurencio  
 

Francis B. Laurencio,

Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  3  

 

EX-99.1 2 atomera_ex9901.htm PRESS RELEASE DATED MAY 6, 2025 ATOMERA INCORPORATED

Exhibit 99.1

 

 

 

 

Atomera Provides First Quarter 2025 Results

 

LOS GATOS, Calif. May 6, 2025 Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2025.

 

Recent Company Highlights

 

· Signed strategic marketing agreement with leading chip fabrication equipment vendor
· Expanded engagements at ST Microelectronics and RFSOI customers to new applications
· Built first ever MST-enabled GaN devices at Sandia and began electrical testing

 

Management Commentary

 

“Our recently announced collaboration with a leading capital equipment company will strengthen Atomera’s deal execution on many different levels. We believe the collaboration will drive our license revenues while growing our partner’s capital equipment tool sales giving incentives for both of us to make it a success,” said Scott Bibaud, President and CEO. “Our expansion to new application areas with ST and our fabless RF licensee are evidence of the growing opportunities available for MST as we deepen our relationships with our lead customers.”

 

Financial Results

 

The Company incurred a net loss of ($5.2) million, or ($0.17) per basic and diluted share in the first quarter of 2025, compared to a net loss of ($4.8) million, or ($0.19) per basic and diluted share, for the first quarter of 2024. Adjusted EBITDA (a non-GAAP financial measure) in the first quarter of 2025 was a loss of ($4.4) million compared to an adjusted EBITDA loss of ($4.0) million in the first quarter of 2024.

 

The Company had $24.1 million in cash, cash equivalents and short-term investments as of March 31, 2025, compared to $26.8 million as of December 31, 2024.

 

The total number of shares outstanding was 30.7 million as of March 31, 2025.

 

First Quarter 2025 Results Webinar

 

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Tuesday, May 6, 2025

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com

 

 

 

 

  1  

 

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

 

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com.  

 

Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics does not proceed with qualification of MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and knowhow and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on March 4, 2025. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

 

-- Financial Tables Follow –

 

 

 

 

 

  2  

 

Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)

 

             
    March 31,     December 31,  
    2025     2024  
    (Unaudited)        
ASSETS                
                 
Current assets:                
Cash and cash equivalents   $ 24,123     $ 25,778  
Short-term investments           995  
Unbilled contracts receivable           6  
Interest receivable     81       73  
Prepaid expenses and other current assets     335       240  
Total current assets     2,4539       27,092  
                 
Property and equipment, net     52       59  
Long-term prepaid maintenance and supplies     91       91  
Security deposit     14       14  
Operating lease right-of-use asset     218       280  
Financing lease right-of-use-asset     1,338       1,588  
                 
Total assets   $ 26,252     $ 29,124  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
                 
Current liabilities:                
Accounts payable   $ 761     $ 492  
Accrued expenses     195       239  
Accrued payroll related expenses     402       1,328  
Current operating lease liability     184       260  
Current financing lease liability     1,314       1,253  
Deferred Revenue           4  
Total current liabilities     2,856       3,576  
                 
Long-term operating lease liability           22  
Long-term financing lease liability     113       449  
                 
Total liabilities     2,969       4,047  
                 
Commitments and contingencies            
                 
Stockholders’ equity:                
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31 2025 and December 31, 2024            
Common stock: $0.001 par value, authorized 47,500 shares; 30,704 shares issued and outstanding as of March 31, 2025; and 30,540 shares issued and outstanding as of December 31, 2024     31       31  
Additional paid in capital     249,981       246,565  
Other comprehensive income (loss)           1  
Accumulated deficit     (226,729 )     (221,520 )
Total stockholders’ equity     23,283       25,077  
Total liabilities and stockholders’ equity   $ 26,252     $ 29,124  

 

 

 

  3  

 

Atomera Incorporated

Condensed Statements of Operations

(in thousands, except per share data)

                   
    Three Months Ended  
    March 31,     December 31,     March 31,  
    2025     2024     2024  
    (Unaudited)     (Unaudited)     (Unaudited)  
Revenue   $ 4       23     $ 18  
Cost of revenue           (13 )     (33 )
Gross margin     4       10       (15 )
                         
Operating expenses                        
Research and development     3,255       2,823       2,858  
General and administrative     2,088       1,811       1,811  
Selling and marketing     124       248       350  
Total operating expenses     5,467       4,882       5,019  
                         
Loss from operations     (5,463 )     (4,872 )     (5,034 )
                         
Other income (expense)                        
Interest income     270       213       205  
Accretion income     6       26       46  
Interest Expense     (21 )     (25 )     (39 )
Other income (expense), net     (1 )     1        
Total other income (expense), net     254       215       212 )
                         
Net loss   $ (5,209 )   $ (4,595 )   $ (4,822 )
                         
Net loss per common share, basic and diluted   $ (0.17 )   $ (0.16 )   $ (0.19 )
                         
Weighted average number of common shares outstanding, basic and diluted     30,243       28,934       26,038  

 

 

 

  4  

 

Atomera Incorporated

Reconciliation to Non-GAAP EBITDA

(Unaudited)

             
    Three Months Ended  
    March 31,     December 31,     March 31,  
    2025     2024     2024  
Net loss (GAAP)   $ (5,209 )   $ (4,657 )   $ (4,822 )
Depreciation and amortization     12       12       17  
Stock-based compensation     1,009       949       1,024  
Interest income     (270 )     (213 )     (205 )
Accretion income     (6 )     (26 )     (46 )
Interest expense     21       25       39  
Other (income) expense, net     1       (1 )      
Net loss non-GAAP EBITDA   $ (4,442 )   $ (3,911 )   $ (3,993 )

 

 

 

 

 

Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633

investor@atomera.com

 

 

 

 

  5  

 

EX-99.2 3 atomera_ex9902.htm INVESTOR PRESENTATION DATED MAY 6, 2025 ATOMERA INCORPORATED

Exhibit 99.2

 

 

 

 

 

 

 

Q1 2025 Conference Call May 6, 2025 Atomera Incorporated 1

 

 

 

 

 

 

 

Safe Harbor This presentation contains forward - looking statements concerning Atomera Incorporated (““Atomera,” the “Company,” “we,” “us,” and “our”). The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “woul d,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forwar d - looking statements. These forward - looking statements are subject to a number of risks, uncertainties and assumptions, including those disclosed in the section "Risk Factors" included in our Annual Report on Form 10 - K filed with the SEC on March 4 , 2025 (the “Annual Report ”). In light of these risks, uncertainties and assumptions, the forward - looking events and circumstances discussed in this presentation may not occur and actual results could differ materially and adversely from those anticipated or implied in our forward - looking statements. You should not rely upon forward - looking statements as predictions of future events. Although we believe that the expectations reflected in our forward - looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward - looking statements will be achieved or occur. This presentation contains only basic information concerning Atomera. The Company’s filings with the Securities Exchange Commission, including the Annual Report, include more information about factors that could affect the Company’s operating and financial results. We assume no obligation to update information contained in this presentation. Although this presentation m ay remain available on the Company's website or elsewhere, its continued availability does not indicate that we are reaffirming or confirming any of the information contained herein.

 

 

 

 

 

 

Atomera Incorporated 2 3 Strong, Growing and Defensible Patent Portfolio High Leverage IP Licensing Business Model Top Tier Management Team Transistor enhancement technology for the $600B semiconductor market Mears Silicon Technology (MST®) Quantum Engineered Materials Strategic Marketing Agreement ► Joint marketing agreement with major semiconductor equipment maker ► Focused on Gate - All - Around transistors ► Enables solutions that are more validated so faster to production Atomera Incorporated 4 ► Leverages partner’s sales and marketing resources ► Partnership may extend into other application areas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MST technology focus areas Atomera 5 MST for Advanced Nodes MST for RF - SOI MST for Power SP, SPX MST for DRAM Customer Status 10 14 2 Engagement Phases Atomera Incorporated 6 Customer Wafer Manufacturing v Customer MST ® Deposition Atomera MST ® Deposition 6 . Production 5 . Qualification 4 . Installation 3 . Integration 2 . Setup 1 . Planning Phase • 21 customers, 26 engagements • Working with more than half of the world’s top semiconductor makers* • At least 10 of the top 20 semiconductor sales leaders with fabs (IC Insights, McClean Report 2023)

 

 

 

 

 

 

 

MST for GaN/Si ► Atomera provides modified Si substrates incorporating MST layers ► GaN growth at various US locations ► Physical characterization indicates fewer defects in GaN device layer ► Electrical characterization in process at Sandia National Lab ► Preliminary electrical data is consistent with lower defects (lower leakage, higher breakdown voltage) ► Sandia National Lab Rapid Access Program renewed in April 2025 5/5/25 Atomera Proprietary 7 Nucleation Stress - relief layers GaN device layers (RF, power, m LED ) Si substrate w/ MST GaN enabling layers MST Si (111) MST silicon substrate Financial Review Atomera Incorporated 8 Income Statement ($ in thousands, except per-share data) March 31, 2025 December 31, 2024 March 31, 2024 REVENUE 4$ 23$ 18$ Gross Profit 4 10 (15) OPERATING EXPENSES Research & Development 3,255 2,823 2,858 General and Administration 2,088 1,811 1,811 Selling and Marketing 124 248 350 TOTAL OPERATING EXPENSES 5,467 4,882 5,019 OPERATING LOSS (5,463) (4,872) (5,034) Other Income (Expense) 254 215 212 NET LOSS (5,209)$ (4,657)$ (4,822)$ Net Loss Per Share (0.17)$ (0.16)$ (0.19)$ Weighted average shares outstanding 30,243 28,934 26,038 ADJUSTED EBITDA (NON-GAAP) (4,442)$ (3,911)$ (3,993)$ ADJUSTED EBITDA PER SHARE (0.15)$ (0.14)$ (0.15)$ Balance Sheet Information Cash, equivalents & ST investments 24,123$ 26,773$ 19,264$ Debt - - - Three Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

We collaborate with customers to improve their products, through integration of MST, so that both companies benefit financially Mission Statement Atomera Incorporated 9 Thank You Atomera Incorporated 10